Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population
NCT02316522 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158
Last updated 2022-05-02
Summary
The main objective is to study the epigenetic contribution to the pathophysiology of diabetic nephropathy in Qatari population.
Conditions
Sponsors & Collaborators
-
Hamad Medical Corporation
collaborator INDUSTRY -
Weill Cornell Medical College in Qatar
collaborator OTHER -
Weill Medical College of Cornell University
lead OTHER
Principal Investigators
-
Charbel Abi Khalil, MD · Weill Cornell Medical College in Qatar
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-10-23
- Primary Completion
- 2018-04-09
- Completion
- 2018-04-09
Countries
- Qatar
Study Locations
More Related Trials
-
Molecular and Clinical Profile of Diabetes Mellitus and Its Complications
NCT01105858 ·Status: SUSPENDED
-
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
NCT05219994 ·Status: COMPLETED ·Phase: NA
-
Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease
NCT06452862 ·Status: RECRUITING
-
Genetic and Epigenetic Risk of T2D in the UAE
NCT04270097 ·Status: UNKNOWN
-
Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.
NCT04931537 ·Status: RECRUITING
-
Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy
NCT04962399 ·Status: UNKNOWN
-
Collection of Gastrointestinal Tissue Samples for the Characterization and ex Vivo Functional Assessment of Chemoreceptors
NCT02859116 ·Status: COMPLETED
-
Epigenetics Based Diagnosis of Diabetes in Saliva and Blood Samples
NCT04011228 ·Status: UNKNOWN
-
Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy
NCT05888909 ·Status: RECRUITING
-
Natural History of Autoimmune Diabetes and Its Complications
NCT00896610 ·Status: TERMINATED
-
Determining Serum and Urinary Levels of miRNA 192 and miRNA 25 in Patients With and Without Type 2 Diabetes.
NCT04176276 ·Status: COMPLETED
-
Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
NCT05368220 ·Status: ENROLLING_BY_INVITATION
-
Epigenetics of Muscle Insulin Resistance
NCT03259984 ·Status: COMPLETED
-
Cardiovascular Disease CVD Constitutes a Significant Health Challenge for Individuals With Type 2 Diabetes Mellitus T2DM, Affecting Approximately 32% of This Population and Contributing Significantly to Global Mortality.Visceral Adipose Tissue VAT Accumulation Has Been Recognize
NCT07204782 ·Status: NOT_YET_RECRUITING
-
Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research
NCT06979037 ·Status: RECRUITING
-
Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy
NCT00237952 ·Status: COMPLETED ·Phase: NA
-
Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers
NCT02325271 ·Status: COMPLETED
-
Coronary Artery Plaque Burden in Asymptomatic Danish Men Aged 65-75 Years and the Relation to Glycemic Status.
NCT04525508 ·Status: COMPLETED
-
Metabolic Phenotypes of Obesity and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
NCT06591104 ·Status: NOT_YET_RECRUITING
-
Impact of Medicaid Health Home on Patients With Diabetes in New York City
NCT02713321 ·Status: COMPLETED
-
Influence of Vasculary Inflammation on Development of Diabetes
NCT01839071 ·Status: COMPLETED ·Phase: NA
-
Cohort Study in Type 2 Diabetes in China
NCT01076023 ·Status: UNKNOWN
-
Identifying Maturity-onset Diabetes of the Young in Emirati Patients
NCT05586594 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
10-year Risk Prediction Models of Complications and Mortality of DM in Hong Kong
NCT03299010 ·Status: COMPLETED
-
Triglyceride-Glucose Index in Diabetic Nephropathy in Type 2diaberes Mellitus Patients
NCT05602532 ·Status: UNKNOWN